Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?

por Zang, Rongyu, Zhu, Jianqing
Publicado en J Gynecol Oncol (2019)

The 5th Shanghai Gynecologic Oncology Group (SGOG)-Korean Gynecologic Oncology Group (KGOG) joint meeting and 2016 Asia-Pacific Ovarian cancer Laparotomy and Laparoscopic Operation...

por Chang, Ha Kyun, Kim, Byoung-Gie, Shi, Ting-Yan, Zang, Rongyu
Publicado en J Gynecol Oncol (2016)

The prognosis of women with stage IB1-IIB node-positive cervical carcinoma after radical surgery

por Cheng, Xi, Cai, Shumo, Li, Ziting, Tang, Meiqin, Xue, Muquan, Zang, Rongyu
Publicado 2004

Can 9q34.2 rs633862 polymorphism predict survival in epithelial ovarian cancer?

por Jiang, Rong, Xu, Yuan, Wang, Pan, Cheng, Xi, Shi, Tingyan, Zang, Rongyu
Publicado en PeerJ (2017)

Cancer-Associated Fibroblast-Derived Interleukin-8 Promotes Ovarian Cancer Cell Stemness and Malignancy Through the Notch3-Mediated Signaling

por Ji, Zhaodong, Tian, Wenjuan, Gao, Wen, Zang, Rongyu, Wang, Huaying, Yang, Gong
Publicado en Front Cell Dev Biol (2021)

Current status of gynecological cancer in China

por Kim, Kidong, Zang, Rongyu, Choi, Seok-Cheol, Ryu, Sang-Young, Kim, Jae Weon
Publicado 2009

Significant association of the EXO1 rs851797 polymorphism with clinical outcome of ovarian cancer

por Shi, Tingyan, Jiang, Rong, Wang, Pan, Xu, Yuan, Yin, Sheng, Cheng, Xi, Zang, Rongyu
Publicado en Onco Targets Ther (2017)

Radical surgery versus standard surgery for primary cytoreduction of bulky stage IIIC and IV ovarian cancer: an observational study

por Ren, Yulan, Jiang, Rong, Yin, Sheng, You, Chao, Liu, Dongli, Cheng, Xi, Tang, Jie, Zang, Rongyu
Publicado en BMC Cancer (2015)

AGO1 may influence the prognosis of hepatocellular carcinoma through TGF-β pathway

por Wang, Miao, Zhang, Lyu, Liu, Zeyang, Zhou, Jiamin, Pan, Qi, Fan, Jia, Zang, Rongyu, Wang, Lu
Publicado en Cell Death Dis (2018)

Fibrillin-1, induced by Aurora-A but inhibited by BRCA2, promotes ovarian cancer metastasis

por Wang, Ziliang, Liu, Yang, Lu, Lili, Yang, Lina, Yin, Sheng, Wang, Yan, Qi, Zihao, Meng, Jiao, Zang, Rongyu, Yang, Gong
Publicado en Oncotarget (2015)

The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy

por Wang, Yan, Wang, Ziliang, Qi, Zihao, Yin, Sheng, Zhang, Na, Liu, Yang, Liu, Mingming, Meng, Jiao, Zang, Rongyu, Zhang, Zhen, Yang, Gong
Publicado 2014

An improved nerve-sparing radical hysterectomy technique for cervical cancer using the paravesico-vaginal space as a new surgical landmark

por Zhang, Yuqin, Shi, Tingyan, Yin, Sheng, Ma, Sining, Shi, Di, Guan, Jun, Xiang, Libing, Liu, Yang, Ren, Yulan, Tan, Deyan, Zang, Rongyu
Publicado en Oncotarget (2017)

Wip1 suppresses ovarian cancer metastasis through the ATM/AKT/Snail mediated signaling

por Yin, Sheng, Wang, Pan, Yang, Lina, Liu, Yang, Wang, Yan, Liu, Mingming, Qi, Zihao, Meng, Jiao, Shi, Ting-Yan, Yang, Gong, Zang, Rongyu
Publicado en Oncotarget (2016)

Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial

por Shi, Tingyan, Jiang, Rong, Yu, Jinjin, Yang, Huijuan, Tu, Dongsheng, Dai, Zhiyuan, Shen, Yang, Zhang, Yuqin, Cheng, Xi, Jia, Huixun, Tu, Ruiqin, Wang, Huaying, Tang, Jie, Luan, Yuting, Cai, Shumo, Zang, Rongyu
Publicado en Br J Cancer (2018)

Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study

por Shi, Tingyan, Jiang, Rong, Pu, Hong, Yang, Huijuan, Tu, Dongsheng, Dai, Zhiyuan, Cai, Yunlang, Zhang, Yuqin, Cheng, Xi, Jia, Huixun, Tu, Ruiqin, Wang, Huaying, Tang, Jie, Luan, Yuting, Cai, Shumo, Zang, Rongyu
Publicado en Br J Cancer (2019)

Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept

por Jiang, Rong, Zhu, Jianqing, Kim, Jae-Weon, Liu, Jihong, Kato, Kazuyoshi, Kim, Hee-Seung, Zhang, Yuqin, Zhang, Ping, Zhu, Tao, Aoki, Daisuke, Yu, Aijun, Chen, Xiaojun, Wang, Xipeng, Zhu, Ding, Zhang, Wei, Jia, Huixun, Shi, Tingyan, Gao, Wen, Yin, Sheng, Feng, Yanling, Xiang, Libing, Okamoto, Aikou, Zang, Rongyu
Publicado en J Gynecol Oncol (2020)

A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study

por Shi, Tingyan, Yin, Sheng, Zhu, Jianqing, Zhang, Ping, Liu, Jihong, Xiang, Libing, Zhu, Yaping, Wu, Sufang, Chen, Xiaojun, Wang, Xipeng, Teng, Yincheng, Zhu, Tao, Yu, Aijun, Zhang, Yingli, Feng, Yanling, Huang, He, Bao, Wei, Li, Yanli, Jiang, Wei, Zhang, Ping, Li, Jiarui, Ai, Zhihong, Zhang, Wei, Jia, Huixun, Zhang, Yuqin, Jiang, Rong, Zhang, Jiejie, Gao, Wen, Luan, Yuting, Zang, Rongyu
Publicado en J Gynecol Oncol (2020)